VivioMD GLP-1 Telehealth Program (2026): Don't Buy Compounded Semaglutide & Tirzepatide Without Reading This First!

NEW YORK, February 7, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links; a commission may be earned at no additional cost to you.

VivioMD GLP-1 Review (2026): Compounded Medication Options, Pricing, Guarantee Fine Print, and What to Verify Before You Enroll

If you've been scrolling through Instagram, TikTok, or Facebook lately, you've probably seen dozens of ads for online GLP-1 weight loss programs. VivioMD is one of them, and if you're reading this, there's a good chance you saw one of those ads and came straight to Google looking for independent details before sharing your health information or purchasing a membership.

That's exactly the right instinct. Before entering your information into any telehealth platform, you deserve a clear, honest breakdown of what VivioMD actually offers, how it works, what it costs, who's behind it, and where the limitations are. That's what this guide delivers.

View the current VivioMD offer (official VivioMD page)

What You Need to Know First: How Compounded GLP-1 Medications Work and What They Are

Before diving into VivioMD specifically, it's important to understand the medication category you're considering. GLP-1 receptor agonists are a class of prescription medications originally developed for type 2 diabetes management. Semaglutide and tirzepatide are the two most widely discussed active ingredients in this category, and they've become recognized for their role in weight management after clinical trials demonstrated significant weight loss outcomes in study populations. VivioMD labels its offerings as GLP-1 and GLP-1+GIP options; the exact active ingredient and formulation for your prescription is determined and disclosed during the clinical evaluation and prescribing process.

Here's where the critical distinction comes in - and this needs to be front and center in your decision-making.

Compounded medications are not reviewed or approved by the FDA as finished products. According to VivioMD's disclosures, the company's medications are prepared as compounded prescriptions by state-licensed pharmacies based on individual prescriptions. Some compounding pharmacies may also be FDA-registered as outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act, depending on the pharmacy. Compounded drug products don't undergo FDA review for safety, effectiveness, or manufacturing quality. That's fundamentally different from picking up a brand-name prescription like Wegovy or Zepbound at your local pharmacy.

That doesn't mean compounded medications are inherently unsafe. It means you should understand the distinction before you start. Brand-name semaglutide (Wegovy) and brand-name tirzepatide (Zepbound) are FDA-approved finished products that have gone through the full FDA review process for safety, effectiveness, and manufacturing quality. Compounded products may be described as semaglutide- or tirzepatide-based depending on the prescription and pharmacy, but the FDA has warned that some compounded products sold as "semaglutide" may contain salt forms (such as semaglutide sodium or semaglutide acetate) that differ from the active ingredient in FDA-approved products. Consumers should confirm the exact compounded ingredient form and dosing instructions with the prescriber and dispensing pharmacy.

According to the company's own disclosures on the VivioMD website: "Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required."

You should also be aware that the FDA has issued safety communications regarding compounded GLP-1 products. In July 2024, the FDA alerted healthcare providers and patients about dosing errors and overdoses associated with compounded injectable semaglutide, reporting cases where patients administered five to twenty times more than the intended dose due to confusion between units of measurement (milliliters, milligrams, and units). The FDA has also warned that some products sold as "semaglutide" may contain salt forms such as semaglutide sodium or semaglutide acetate, which differ from the active ingredient in FDA-approved products and have not been evaluated for safety or effectiveness. For more information, review the FDA's compounding risk alerts at fda.gov/drugs/human-drug-compounding/compounding-risk-alerts. This is an evolving regulatory area, and staying informed about current FDA guidance is part of making a well-informed decision about any compounded medication.

VivioMD discloses the compounded status of its products on its website, which allows consumers to factor this information into their decision-making. Platforms that bury or avoid this distinction should raise more concern than platforms that state it clearly.

The Three Entities Behind Your VivioMD Experience

One of the most important things to understand about any telehealth platform is who's actually involved in your care. VivioMD operates with a three-entity structure that's common across telehealth, and understanding it helps you know exactly who's responsible for what.

VivioMD Group LLC functions as the telehealth platform connecting patients with healthcare providers. According to the company's published information, VivioMD Group LLC is located at 16192 Coastal Highway, Lewes, DE 19958. The platform provides the technology infrastructure, customer service, and coordination that makes the telehealth experience work. VivioMD itself is not a healthcare provider.

OpenLoop Healthcare Partners P.C. and affiliated professional entities are the independent medical groups providing the actual clinical care. These are licensed, independent healthcare professionals who review your information and determine whether a prescription is appropriate. The prescribing decision rests entirely with the evaluating clinician - not with VivioMD as a platform. According to VivioMD's disclosures, OpenLoop maintains a network of U.S.-based healthcare providers. The platform can't guarantee that any individual will receive a prescription, as that determination rests entirely with the evaluating clinician.

Partner pharmacies fulfill prescriptions written by the medical providers. According to the VivioMD website, the platform works with four named partner pharmacies: RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Compounding Pharmacy in New York, and Triad Rx in Alabama. These are licensed U.S. pharmacies that compound and dispense medications according to the prescriptions they receive.

This three-entity structure ensures appropriate separation between the technology platform, clinical decision-making, and medication dispensing. It's a standard model across telehealth, and the fact that VivioMD names its pharmacy partners specifically is a transparency signal worth noting.

What VivioMD Offers: Medication Options and Pricing Breakdown

According to VivioMD's official landing page, the platform advertises four GLP-1 and GLP-1+GIP program formats (injection and oral dissolving tablet options) for weight management. All pricing below comes from the company's landing page and was accurate at the time of this publication in February 2026. Pricing is subject to change, so always verify current details directly on the official website before ordering.

Compounded GLP-1 Injection is listed at $249 per month on the VivioMD landing page. In the broader market, GLP-1 single-agonist formulations are commonly associated with semaglutide, the active ingredient in brand-name Wegovy, which is FDA-approved for chronic weight management. The exact formulation and active ingredient are confirmed during the clinical prescribing and pharmacy fulfillment process. VivioMD's compounded products are separate from brand-name medications and haven't undergone individual FDA review as finished products.

Compounded GLP-1+GIP Injection is listed at $339 per month according to the landing page. In the broader GLP-1 market, GLP-1+GIP dual-agonist formulations are commonly associated with tirzepatide, the active ingredient in brand-name Zepbound. However, VivioMD's landing page product card text for this option doesn't consistently identify the specific active ingredient. Important: VivioMD's own GLP-1+GIP injection card contains inconsistent labeling (the card text references compounded semaglutide), so patients should confirm the exact active ingredient and form during the clinician evaluation and again with the dispensing pharmacy before starting. If the specific active ingredient is important to your decision, confirm it directly with VivioMD or during your clinical consultation before committing.

Compounded GLP-1 Oral Dissolving Tablets are listed at $279 per month. This option is designed for people who'd rather not use injections. According to the landing page, these are oral dissolving tablets in the GLP-1 category. This format has become increasingly relevant heading into 2026, particularly as needle-free GLP-1 options gain broader market attention. VivioMD's oral dissolving tablets are compounded products and are not the same as the FDA-approved oral formulation of Wegovy, which is a branded, FDA-approved product that went through the full FDA review process. These are different products with different regulatory standing.

Compounded GLP-1+GIP Oral Dissolving Tablets are listed at $339 per month. As with the GLP-1+GIP injection above, VivioMD labels this as a GLP-1+GIP option in oral dissolving tablet format. Confirm the exact active ingredient with the evaluating clinician or dispensing pharmacy.

Per VivioMD's official landing page, the company is currently advertising a $100 discount on the first month for new patients along with free shipping on all orders. The company also states that HSA and FSA payments are accepted. Verify all current promotional offers, pricing, and payment options directly on the official website before ordering, as these details are subject to change.

View the current VivioMD offer (official VivioMD page)

How VivioMD's Enrollment Process Works

Understanding what happens after you click the button matters for setting realistic expectations. Based on information published on the VivioMD website, the process follows these general steps.

The first step is completing what the company describes as a quick health assessment through the platform. You'll provide information about your medical history, current medications, weight management goals, and other health factors that a clinician would need to evaluate your eligibility for GLP-1 medications.

After you submit your assessment, an independent medical provider from the OpenLoop network reviews your information. This is the clinical decision-making step - a licensed healthcare professional determines whether a GLP-1 prescription is appropriate for your specific situation. Not everyone who applies will receive a prescription. The evaluating clinician may determine that GLP-1 medication isn't appropriate based on your health profile, existing conditions, or other factors.

If the clinician determines that treatment is appropriate and writes a prescription, it's sent to one of VivioMD's partner pharmacies for compounding and fulfillment. The company's landing page advertises 3-day delivery. Verify current shipping timelines directly with the company, as delivery times may vary.

According to the VivioMD website, the company states that members have ongoing access to clinical support, describing this as including access to nurse practitioners, doctors, and nutrition specialists for progress tracking, dosage adjustments, and questions throughout your treatment. The website uses the phrase "24/7" in describing this access. Verify the specifics of clinical support availability directly with VivioMD, as actual response times and support hours may vary.

How VivioMD's Pricing Compares to Other GLP-1 Access Points

Understanding where VivioMD sits in the broader GLP-1 pricing landscape helps you make an informed decision. The following ranges are general illustrative examples based on typical out-of-pocket pricing and aren't specific to any particular practice or insurer. Actual costs vary by location, provider, and insurance.

Brand-name Wegovy (semaglutide injection), without insurance, can carry a list price that runs over $1,000 per month depending on the pharmacy and available discount programs. Brand-name Zepbound (tirzepatide injection) carries a similar premium price point without insurance. Some manufacturer cash-pay programs and pharmacy discount programs have brought these costs down significantly for eligible patients, but access and pricing continue to evolve.

Compounded GLP-1 telehealth platforms like VivioMD generally position themselves as more accessible alternatives for people paying out of pocket. According to VivioMD's landing page, their compounded GLP-1 injection starts at $249 per month, which falls in the mid-range among compounded GLP-1 telehealth platforms. Some competitors offer compounded semaglutide at lower monthly starting prices, while others charge more.

The important consideration isn't just monthly cost but the total value equation: what's included in that monthly price, what level of clinical support comes with it, which pharmacies are compounding the medications, and what happens if you have questions or need dosage adjustments between scheduled check-ins. These factors vary significantly across platforms and are worth evaluating alongside the headline price.

Many direct-to-consumer prescription products like those offered through VivioMD aren't covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA and FSA plans may reimburse qualifying expenses. According to VivioMD, the platform accepts HSA and FSA payments, but check your specific plan rules to confirm eligibility.

The VivioMD Weight Loss Guarantee: Read the Fine Print

VivioMD markets what the company calls a weight loss guarantee on its website. According to VivioMD's Terms of Use, if you don't lose at least 10% of your body weight, you may be eligible for a refund - subject to extensive conditions. That language sounds compelling in the headline, but the actual Terms reveal significant qualification requirements worth understanding before you sign up.

Based on the Terms of Use published on the VivioMD website, the guarantee requires completion of 24 consecutive weeks of continuous participation in the program - not just a few weeks or a couple of months. Within that 24-week period, you must also meet multiple eligibility conditions, including a minimum of at least 16 consecutive weeks of active participation, consistent weekly dosing as prescribed, adherence to provider recommendations, and completion of required tracking and check-in activities specified in the company's terms.

Here's the part that matters most for your financial planning: according to the Terms of Use, the refund applies to the membership portion of your payments. Medication costs are non-refundable once dispensed. Additionally, refunds, if granted, are reduced by costs already incurred - provider consultations, laboratory services, or administrative fees. That means if you qualify for the guarantee refund, you wouldn't be getting back the full amount you spent over 24 weeks. The medication itself, once compounded and shipped, is a separate cost not covered by the guarantee, and service costs already delivered are deducted from any refund amount.

How refunds actually work, according to the Terms of Use. Medication orders become final once the provider approves the prescription and it's submitted to the pharmacy. After that point, medication can't be canceled, returned, or refunded. VivioMD states that it may issue refunds at its sole discretion for the membership portion, and that refunds are processed by the Medical Groups (the OpenLoop clinical entities), not by VivioMD directly. The combination of these mechanics means the practical refund amount - if you qualify - may be significantly less than your total spending over the 24-week period.

Before relying on this guarantee as a financial safety net, review the complete terms and conditions directly on the VivioMD website at viviomd.com/terms-of-use or contact the company's customer support at (678) 258-9290 for clarification on the specific eligibility requirements and what the refund covers. This guarantee is the company's refund policy, not a guarantee of specific health outcomes. Individual results will always vary based on factors including starting weight, metabolic profile, medication adherence, lifestyle factors, and other individual variables.

Who VivioMD May Be Right For

This section is designed to help you figure out whether VivioMD aligns with your specific situation. Rather than relying on cherry-picked success stories, consider whether the platform's characteristics match your needs.

People who want both injection and oral GLP-1 options from the same platform. Not all telehealth GLP-1 programs offer both injectable and oral dissolving tablet formats. If you're not sure whether you want to commit to weekly injections or you strongly prefer a needle-free option, VivioMD's range of four medication formats gives you and your evaluating clinician more flexibility to find what works.

People paying out of pocket who want a mid-range pricing option. At $249 per month for compounded GLP-1 injections according to the company's landing page, VivioMD sits in the middle of the compounded GLP-1 telehealth market. If brand-name medications are out of your budget and you want something between the lowest-cost and highest-cost compounded options, VivioMD's pricing may fit your financial situation.

People who value knowing exactly which pharmacies are compounding their medication. VivioMD names its four partner pharmacies on its website. That level of pharmacy transparency isn't universal across all telehealth platforms, and for people who want to research the specific pharmacies handling their prescriptions, this information is readily available.

People who want both GLP-1 and GLP-1+GIP options from the same platform. Some platforms only offer GLP-1 (semaglutide-category) options. VivioMD offers both GLP-1 and GLP-1+GIP options in injection and oral formats, which gives the evaluating clinician a broader set of options to consider based on your health profile. Confirm specific active ingredients during your clinical consultation.

Other Options May Be Preferable For People Who

Have insurance that covers brand-name GLP-1 medications. If your insurance covers Wegovy or Zepbound, brand-name FDA-approved medications may be a more straightforward option than compounded alternatives. The FDA review process for brand-name products provides an additional layer of quality verification that compounded products don't have.

Want the lowest possible monthly cost above all other factors. Some compounded GLP-1 telehealth platforms offer starting prices below VivioMD's $249 per month for GLP-1 injections. If your primary decision factor is the lowest monthly price, other platforms may better fit that criterion - but evaluate what's included in lower-priced options before deciding based solely on price.

Prefer in-person medical oversight. Telehealth is convenient, but some people prefer or benefit from in-person consultations, especially when starting a new prescription medication. If having a face-to-face relationship with your prescribing provider matters to you, a local weight management clinic or endocrinologist may be a better fit than any telehealth platform.

Are pregnant, nursing, or planning to become pregnant. GLP-1 medications are generally not recommended during pregnancy or while nursing. If any of these apply to you, consult your OB-GYN or primary care physician before considering any GLP-1 medication program.

Questions to Ask Yourself

Before choosing any GLP-1 telehealth platform, including VivioMD, consider the following.

Have you discussed weight management medication with your primary care physician? A telehealth platform isn't a replacement for your existing medical relationships, and your doctor's input is valuable context for any treatment decision.

Are you comfortable with compounded medications, or would you prefer FDA-approved brand-name products? Understanding this distinction - and your comfort level with it - is an important part of making an informed decision.

What's your realistic monthly budget for weight management medication, and can you sustain it for the duration needed to see results? GLP-1 medications aren't one-month solutions. According to general clinical guidance, meaningful weight management results with GLP-1 medications typically require sustained use over months.

Do you have a preference for injections or oral tablets? If needles are a barrier, VivioMD's oral dissolving tablet options may address that concern, but it's worth discussing the format differences with the evaluating clinician.

Have you checked whether your insurance covers brand-name alternatives? Before committing to out-of-pocket compounded medication costs, it's worth confirming what your insurance plan covers.

Your answers to these questions help determine which GLP-1 pathway - and which specific platform characteristics - matter most for your situation.

View the current VivioMD offer (official VivioMD page)

Safety Considerations for GLP-1 Medications Through VivioMD

VivioMD's medications contain prescription-strength active ingredients. They're generally well-tolerated when used as directed under medical supervision, but you should understand what to expect. The following points are a high-level overview, not a complete list of risks or precautions.

Common side effects associated with GLP-1 medications in general include nausea (particularly during initial weeks and dose escalation periods), digestive discomfort, constipation or diarrhea, and decreased appetite. These are among the most frequently reported side effects in clinical studies of both semaglutide and tirzepatide. Most side effect profiles improve as the body adjusts, but individual experiences vary.

Tirzepatide (GLP-1+GIP dual agonist) side effects may differ somewhat from semaglutide-only formulations because tirzepatide targets both GLP-1 and GIP receptors. Clinical studies of brand-name tirzepatide documented similar gastrointestinal side effects, with some differences in frequency and severity compared to semaglutide. Discuss the specific considerations of each medication format with your evaluating clinician.

Oral dissolving tablets versus injections may have different side effect profiles and bioavailability considerations. The oral format is a newer delivery method for compounded GLP-1 medications, and your prescribing clinician can discuss what to expect with each format based on your health profile.

Drug interactions and contraindications exist for GLP-1 medications. If you're currently taking medications for diabetes, thyroid conditions, or other health conditions, your evaluating clinician needs complete information about your medication regimen to make an appropriate prescribing decision. Don't start GLP-1 medication without disclosing all current medications and health conditions.

VivioMD's service is intended for adults 18 and older based on the platform's published eligibility criteria. Any considerations outside this age range would need to be specifically determined by a licensed clinician on a case-by-case basis.

This isn't a replacement for prescribed medical treatment for any health condition. Always consult your physician if you have health concerns, take other medications, or have any questions before starting any new prescription treatment.

Note: This safety overview isn't exhaustive and doesn't replace the Patient Drug Education or official prescribing information. Always review the full safety information that comes with your prescription and consult your prescriber or pharmacist with any questions.

Realistic Expectations: What GLP-1 Weight Management Results Actually Look Like

Managing expectations is one of the most important things you can do before starting any GLP-1 program. The ads show dramatic transformations, but real-world results follow a more nuanced pattern.

VivioMD's website references figures including "up to 15% weight loss" and states that over 231,650 pounds have been lost with the platform and that more than 120,000 prescriptions have been written. These are the company's stated figures. The "up to 15% weight loss" reference appears tied to clinical trial data for semaglutide in general study populations, not to VivioMD-specific patient outcomes.

VivioMD doesn't publish a week-by-week guaranteed timeline for results. Based on how GLP-1 medications are generally used in clinical practice - and on the pharmacology of these medications - people may notice changes along a rough pattern, although individual experiences vary widely.

During the first few weeks, most protocols involve a lower starting dose to let the body adjust, and noticeable weight changes during this period are typically modest. Dose escalation happens gradually over the following weeks under clinician guidance. The period around weeks four through eight is when many people in clinical studies began noticing more measurable changes, though this varies significantly between individuals. Sustained use over several months is generally where the clinical literature shows the most meaningful outcomes.

That said, not everyone responds the same way. Some people see significant changes. Others see modest changes. Some may not respond as expected. Factors including starting weight, metabolic profile, medication adherence, dietary patterns, physical activity, genetics, existing health conditions, and dozens of other variables all play a role.

Results aren't guaranteed, regardless of which platform or medication format you choose.

How to Verify VivioMD: Licenses, Terms, Pharmacy Partners, and Disclosures

If you arrived at this article searching whether VivioMD is legitimate, you're asking the right question. Here's how to conduct your own due diligence on any GLP-1 telehealth platform.

Verify the company's registered business information. According to publicly available information, VivioMD Group LLC lists a registered address at 16192 Coastal Highway, Lewes, DE 19958. You can verify corporate registration through the Delaware Division of Corporations or similar state business registries.

Check the medical provider network. VivioMD states that clinical services are provided through OpenLoop Healthcare Partners P.C. and affiliated professional entities. OpenLoop is a known telehealth infrastructure provider that works with multiple telehealth platforms. You can verify their standing independently.

Research the partner pharmacies. VivioMD names four specific partner pharmacies. State pharmacy licensing boards maintain public databases where you can verify whether those pharmacies are currently licensed and in good standing. This is a concrete verification step you can take.

Review the Terms of Use and Privacy Policy. These documents, available on VivioMD's website, disclose important information about data handling, refund policies, guarantee terms, and the relationship between the platform, medical providers, and pharmacies. Reading these before signing up is strongly recommended.

Look for transparent communication about compounding status. Legitimate compounded GLP-1 platforms are upfront about the fact that their products aren't FDA-approved finished products. VivioMD includes this disclosure on its website. Platforms that obscure or avoid this distinction should raise more concern.

The company publishes customer reviews on its website. Reviews are self-published and may not represent typical outcomes; results vary. Satisfied customers are more likely to leave feedback than those with neutral or negative experiences, so consider reviews as one data point among many - not as representative of what you should expect.

The February 2026 GLP-1 Landscape: Why Context Matters for Your Decision

If you're making this decision right now, in early 2026, the GLP-1 telehealth market is evolving rapidly. Understanding the current landscape helps you evaluate VivioMD in context rather than in isolation.

The FDA approved an oral formulation of Wegovy (brand-name semaglutide) in December 2025, which has increased attention on needle-free GLP-1 options across the entire market. VivioMD's oral dissolving tablet offerings are positioned within this broader trend toward non-injection GLP-1 access. However, the distinction matters: VivioMD's oral dissolving tablets are compounded products prepared by the platform's partner pharmacies, while the FDA-approved oral formulation of Wegovy is a branded, FDA-approved product manufactured by Novo Nordisk that has undergone the full FDA review process. These are different products with different regulatory standing, and they shouldn't be confused with each other.

Multiple telehealth platforms are competing aggressively on pricing, format options, and clinical support features. That competition is generally positive for consumers because it drives transparency and pricing pressure. At the same time, it means you have more options to evaluate and more claims to verify.

The compounded GLP-1 telehealth space exists in part because brand-name GLP-1 medications remain expensive for many people paying out of pocket. As manufacturer pricing programs, insurance coverage, and potential government initiatives continue to evolve, the value proposition of compounded alternatives may shift over time. Making decisions based on the current pricing landscape - while staying aware that it's subject to change - is a practical approach.

View the current VivioMD offer (official VivioMD page)

What to Ask Your Prescriber and Pharmacy Before Starting

If you enroll in VivioMD or any compounded GLP-1 telehealth program, these are the specific questions worth asking during your clinical consultation and after receiving your prescription. Getting clear answers protects you and ensures you're making a fully informed decision.

Ask the prescriber about the exact compounded ingredient form. Confirm whether your prescription contains semaglutide base, tirzepatide, or a salt form such as semaglutide sodium or semaglutide acetate. The FDA has specifically warned that salt forms haven't been evaluated for safety or effectiveness. Knowing exactly what's in your prescription is your right as a patient.

Ask about dosing units and how to measure correctly. The FDA's July 2024 safety alert specifically cited confusion between milliliters, milligrams, and units as a cause of serious overdoses with compounded injectable semaglutide. If your prescription is an injectable, make sure you understand exactly how to measure and administer the correct dose. Ask for a demonstration if needed.

Ask about the titration schedule. GLP-1 medications typically start at a lower dose and increase gradually. Confirm your specific dose escalation timeline, when adjustments will happen, and who initiates those adjustments.

Ask the dispensing pharmacy about storage and shipping handling. Compounded medications may have specific storage requirements (such as refrigeration) that differ from brand-name products. Confirm how the medication is shipped, how to store it when it arrives, and what the shelf life is.

Ask about what happens if you experience side effects. Know who to contact, how quickly you can expect a response, and what the protocol is for dosage adjustments if side effects are significant. Confirm whether you should reach out to VivioMD's support team, the OpenLoop clinical team, or the pharmacy directly.

Ask about refill timing and cancellation terms. Understand when refills are processed, how far in advance you need to cancel or pause, and whether there are any cancellation fees or auto-renewal terms. Review these details in the Terms of Use before your first payment.

Compounding Red Flags: What the FDA Warns Consumers to Watch For

The FDA has published guidance that helps consumers evaluate any compounded medication program. Based on FDA safety communications, here are specific red flags that apply across all compounded GLP-1 providers - not just VivioMD.

Unclear ingredient disclosure. If a platform or pharmacy can't clearly tell you exactly what active ingredient is in your compounded medication and in what form, that's a red flag. You have the right to know precisely what you're putting in your body.

Salt forms without disclosure. The FDA has specifically warned about products sold as "semaglutide" that actually contain semaglutide sodium or semaglutide acetate. These salt forms haven't been shown to be safe and effective. Ask whether your compounded prescription uses the base form or a salt form of the active ingredient.

Confusing or missing dosing instructions. The FDA's July 2024 alert cited dosing confusion as a primary cause of serious adverse events with compounded semaglutide. If your medication arrives without clear, specific dosing instructions that match what your prescriber discussed, contact your prescriber and pharmacy before using it.

No pharmacy disclosure. If a telehealth platform doesn't tell you which pharmacy is compounding and dispensing your medication, that limits your ability to verify licensing and compliance. VivioMD does name its partner pharmacies, which allows you to verify their standing through state pharmacy board databases.

No prescriber entity disclosure. If you can't identify the clinical entity responsible for your prescription, that reduces accountability. Legitimate platforms identify the medical group providing clinical services.

Pressure to skip the clinical evaluation. Any platform that guarantees a prescription before a clinical evaluation - or that makes the evaluation feel like a formality rather than a genuine medical assessment - should raise concern. The prescribing decision should always rest with the evaluating clinician based on your individual health factors.

For the most current FDA guidance on compounded medications, visit fda.gov/drugs/human-drug-compounding/compounding-risk-alerts.

Frequently Asked Questions About VivioMD

Is VivioMD the same as getting Wegovy or Ozempic?

No. VivioMD offers compounded GLP-1 and GLP-1+GIP medications, which the company labels as injection and oral dissolving tablet formats. These aren't the same as FDA-approved brand-name products like Wegovy, Ozempic, Zepbound, or Mounjaro. Compounded medications are prepared by state-licensed pharmacies based on individual prescriptions but aren't reviewed or approved by the FDA as finished products. The exact active ingredient in your prescription is determined during the clinical evaluation and confirmed by the dispensing pharmacy.

Can VivioMD guarantee I'll lose weight?

No telehealth platform can guarantee weight loss outcomes. VivioMD does offer what the company calls a weight loss guarantee, which is structured as potential eligibility for a membership-portion refund if you don't lose 10% of body weight by the end of 24 consecutive weeks of continuous participation. The guarantee is subject to extensive qualification criteria outlined in the company's Terms of Use, including minimum participation weeks, consistent dosing, and tracking requirements. Medication costs are non-refundable once dispensed, and any refund is reduced by costs already incurred for consultations, labs, and administrative services. This is a refund policy, not a medical outcome guarantee. Individual results vary significantly.

Will I definitely get a prescription through VivioMD?

No. The decision to prescribe medication rests entirely with the independent evaluating clinician, not with VivioMD as a platform. Based on your health assessment, medical history, current medications, and other factors, the clinician may determine that GLP-1 medication isn't appropriate for you. Not everyone who applies through a telehealth platform will receive a prescription.

Are compounded GLP-1 medications safe?

Compounded medications are prepared by licensed pharmacies under federal and state compounding regulations. The evaluating clinician determines whether this option is appropriate based on your individual health factors. However, compounded medications haven't undergone individual FDA review for safety, effectiveness, or quality as finished products. Discuss the specific benefits and risks with your prescribing clinician and review the full safety information provided with your prescription.

How does VivioMD compare to other GLP-1 telehealth platforms?

VivioMD is one of many compounded GLP-1 telehealth platforms operating in 2026. Each platform differs in pricing, medication formats offered, clinical support models, pharmacy partners, and other features. Rather than declaring any single platform the best option, evaluate the factors that matter most to your specific situation: medication format preferences, monthly budget, level of clinical support you want, pharmacy transparency, and whether the platform offers the specific GLP-1 options you and your clinician are considering.

What happens if I want to stop or switch medications?

According to VivioMD's website, the platform provides ongoing clinical support including access to providers who can discuss dosage adjustments or medication changes. Review the company's cancellation and subscription management policies in their Terms of Use before enrolling. Any decision to stop, adjust, or switch GLP-1 medications should be made in consultation with your prescribing clinician.

Can I use my HSA or FSA for VivioMD?

According to the company's website, VivioMD accepts HSA and FSA payments. However, HSA and FSA eligibility rules vary by plan. Confirm with your specific plan administrator that compounded prescription medications from a telehealth platform qualify as an eligible expense under your plan before relying on this payment method.

How to Get Started With VivioMD

If you've reviewed this information and decided VivioMD is worth exploring further, the enrollment process begins on the company's website.

According to VivioMD's website, the process starts with a brief online health assessment where you provide information about your medical history, health goals, and current medications. That information is reviewed by an independent medical provider from the OpenLoop network who determines whether a prescription is clinically appropriate for your situation.

If a prescription is issued, your compounded medication is prepared by one of the four named partner pharmacies and shipped directly to your address. The company's landing page advertises 3-day delivery, though actual delivery times may vary. Verify current shipping timelines at the time of your order.

Contact Information

For questions before or during the enrollment process, according to the company's website, VivioMD offers customer support through the following channels.

Phone: (678) 258-9290 (sales and general questions, per the landing page)

Phone: (929) 822-5201 (corporate contact, per the Terms of Use)

Email: [email protected]

Address: VivioMD Group LLC, 16192 Coastal Highway, Lewes, DE 19958

View the current VivioMD offer (official VivioMD page)

Weighing the Evidence: What VivioMD Offers and What to Consider for 2026

How VivioMD Positions Its Program. The platform advertises four GLP-1 and GLP-1+GIP program formats, including both injectable and oral dissolving tablet options. The company names its partner pharmacies, provides transparent pricing on its landing page, and clearly discloses the compounded status of its medications. The mid-range pricing - $249 per month for compounded GLP-1 injections according to the landing page - positions VivioMD accessibly for people paying out of pocket who can't afford brand-name GLP-1 medications. The inclusion of oral dissolving tablets addresses the significant needle-averse segment of potential GLP-1 users. And the company's stated clinical support model, which the website describes as including access to healthcare professionals, addresses one of the most common concerns about telehealth weight management: feeling unsupported between check-ins. The website uses the phrase "24/7" when describing this access; verify actual support availability directly with the company.

Considerations to Weigh. Compounded GLP-1 medications aren't FDA-approved finished products, and that distinction carries real significance regarding quality assurance and regulatory oversight compared to brand-name alternatives. VivioMD's weight loss guarantee requires 24 consecutive weeks of participation with extensive qualification criteria, and the refund applies to the membership portion only - not medication costs. The platform's self-published outcome figures and review numbers represent the company's claims and haven't been independently verified. The GLP-1+GIP product labeling on the landing page contains an apparent inconsistency regarding the active ingredient, which is worth clarifying directly with the company before enrolling if the specific medication matters to your decision. And while the pricing is more accessible than brand-name medications, it still represents a significant monthly financial commitment you'll need to sustain over several months to align with how GLP-1 medications are generally used in clinical practice.

Important Note: The GLP-1 telehealth and compounded medication space has been under increased regulatory scrutiny in recent years, including attention from the FDA regarding compounded versions of GLP-1 medications. Patients should review the most current information about any telehealth platform's compliance, quality standards, and regulatory standing before starting treatment. Regulatory developments in this space are ongoing and may affect the availability or terms of compounded GLP-1 medications.

The decision to start any prescription medication is a personal one that should involve your own research, an honest self-assessment of your health situation, consultation with healthcare professionals you trust, and a clear understanding of what you're signing up for. VivioMD provides one pathway among several. Whether it's the right one for you depends on factors that only you and your clinician can evaluate.

View the current VivioMD offer (official VivioMD page)

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. VivioMD offers access to compounded prescription medications that require evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. GLP-1 medications are not a substitute for prescribed medical treatment for any underlying health condition. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new prescription treatment through VivioMD or any other platform. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.

Compounded Medication Notice: VivioMD's medications are compounded prescription medications prepared by state-licensed pharmacies based on individual prescriptions. Some compounding pharmacies may also be FDA-registered as outsourcing facilities under Section 503B, depending on the pharmacy. Compounded medications are not reviewed or approved by the FDA as finished products. According to VivioMD's disclosures, compounded drug products do not undergo FDA review for safety, effectiveness, or manufacturing quality. Unlike FDA-approved drugs, compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before they are dispensed; they are prepared by pharmacies under federal and state compounding rules. The evaluating clinician determines whether this option is appropriate based on individual health factors.

Results May Vary: Individual results will vary based on factors including age, baseline weight and health condition, metabolic profile, genetic factors, medication adherence, dietary habits, physical activity levels, existing health conditions, current medications, and other individual variables. While some customers report improvements, results are not guaranteed. Weight management outcomes depend on numerous factors beyond medication alone.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All opinions and descriptions are based on published research and publicly available information.

Pricing Disclaimer: All prices, discounts, and promotional offers mentioned were sourced from VivioMD's official landing page (viviomd.com/landing) and were accurate at the time of publication (February 2026) but are subject to change without notice. Guarantee and refund terms are governed by the company's Terms of Use (viviomd.com/terms-of-use) and Refund Policy (viviomd.com/refund-policy). Always verify current pricing, terms, and promotional offers on the official VivioMD website before making your purchase.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with VivioMD and their healthcare provider before making decisions.

Insurance Coverage Note: Many direct-to-consumer prescription products are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA and FSA plans may reimburse qualifying expenses; check your specific plan rules.

SOURCE: VivioMD

Source: VivioMD